Flunixin
Who holds supplier records for Flunixin? 9 organisations hold a current record for Flunixin: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3) and China (3); not recorded for 3.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Flunixin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/flunixin
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Flunixin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AUTHENTERRA HEALTHCARE LLPIndiaActive DMF 43163 · latest filing Dec 2025
- IndiaCEP
- ISP CHEMICALS INCCEP
- MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTDCEP
- IndiaCEP
- NORBROOK LABORATORIES LTDCEP
- Qilu SYNVA Pharmaceutical Co., Ltd.ChinaCEP
- Shandong Lukang Shelile Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
- ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Flunixin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam | IN | CEP 2022-371 - Rev 05 Flunixin meglumine for veterinary use, Process-II | Oct 2026 | — |
| NGL FINE-CHEM LIMITED Mumbai | IN | CEP 2022-160 - Rev 01 Flunixin meglumine for veterinary use | Jun 2026 | — |
| ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2016-133 - Rev 01 Flunixin meglumine for veterinary use, Process II | Feb 2026 | — |
| QILU SYNVA PHARMACEUTICAL CO., LTD. Dezhou | CN | CEP 2015-371 - Rev 01 Flunixin meglumine for veterinary use | Nov 2024 | — |
| MINSHENG GROUP SHAOXING PHARMACEUTICAL CO., LTD. Shaoxing | CN | CEP 2022-493 - Rev 00 Flunixin meglumine for veterinary use | May 2024 | — |
| SHANDONG LUKANG SHELILE PHARMACEUTICAL CO., LTD. Zoucheng | CN | R1-CEP 2016-099 - Rev 00 Flunixin meglumine for veterinary use | Jul 2022 | — |
| ISP CHEMICALS LLC Columbus | US | R1-CEP 2006-109 - Rev 00 Flunixin meglumine for veterinary use | Sept 2014 | — |
| NORBROOK LABORATORIES LIMITED Newry | IE | R1-CEP 2006-141 - Rev 00 Flunixin meglumine for veterinary use | Mar 2012 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Flunixin are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Germany · Inactive DMF 12286 · filed Dec 1996
- SELOC FRANCEInactive DMF 10765 · filed Mar 1994
Overview
Flunixin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1617398).
Chemical identity
- IUPAC name
- 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid
- Canonical SMILES
- CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F
- InChIKey
- NOOCSNJCXJYGPE-UHFFFAOYSA-N
- Synonyms
- Flunixin, Flunixine, Flunixino, SCH 14714, SCH-14714, Flunixinum, CHEBI:76138, Banamine-S, Banamine Transdermal, RefChem:57817, Flunixin [USAN], Flunixine [INN-French]
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Flunixin?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Flunixin: AUTHENTERRA HEALTHCARE LLP (India), Alivira Animal Health Limited (India), ISP CHEMICALS INC, MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTD, Ngl Fine Chem Limited (India), NORBROOK LABORATORIES LTD, Qilu SYNVA Pharmaceutical Co., Ltd. (China) and Shandong Lukang Shelile Pharmaceutical Co., Ltd. (China), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Flunixin Drug Master Files are active?
AUTHENTERRA HEALTHCARE LLP (DMF 43163). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Flunixin records mean?
2 organisations have only inactive Type II DMFs for Flunixin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Flunixin have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Flunixin on the EDQM register, including ALIVIRA ANIMAL HEALTH LIMITED Visakhapatnam (IN), NGL FINE-CHEM LIMITED Mumbai (IN), ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD. Taizhou (CN), QILU SYNVA PHARMACEUTICAL CO., LTD. Dezhou (CN), MINSHENG GROUP SHAOXING PHARMACEUTICAL CO., LTD. Shaoxing (CN) and SHANDONG LUKANG SHELILE PHARMACEUTICAL CO., LTD. Zoucheng (CN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Flunixin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Flunixin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.